4.7
Bronchopneumopathie chronique obstructive III: Caractéristiques de la bronchite chronique
La bronchite chronique est un phénotype majeur de la bronchopneumopathie chronique obstructive, ou BPCO, caractérisé par une inflammation centrée sur…
La bronchite chronique, un phénotype majeur de la MPOC, résulte d’une exposition prolongée à des irritants aériens tels que la fumée de cigarette.
Ces irritants déclenchent une inflammation persistante qui commence dans les grandes bronches et s’étend dans les voies respiratoires plus petites.
Les neutrophiles, macrophages et lymphocytes infiltrent les parois bronchiques, causant des lésions épithéliales.
L’inflammation provoque également une métaplasie squameuse, qui remplace l’épithélium cilié par des cellules squameuses, altère la dégagement mucociliaire.
Pendant ce temps, les cellules gobelets et les glandes sous-muqueuses subissent une hyperplasie et une hypertrophie, produisant un mucus épais qui obstrue les voies respiratoires et favorise l’infection.
Une inflammation persistante et un bouchon du mucus entraînent un remodelage des voies respiratoires, notamment une hypertrophie musculaire lisse et une fibrose, qui rétrécissent les voies respiratoires, surtout lors de l’expiration.
L’obstruction des voies respiratoires crée un décalage ventilation-perfusion, entraînant une hypoxémie. Le piégeage progressif de l’air provoque une hyperinflation, ce qui aplatit le diaphragme, réduit l’efficacité ventilatoire et augmente le travail de respiration.
View the full transcript and gain access to JoVE Core videos
Q1: What causes chronic bronchitis to develop?
Chronic bronchitis develops from prolonged exposure to airborne irritants, most commonly cigarette smoke. These irritants trigger persistent inflammation that begins in the larger bronchi and extends into smaller airways. Neutrophils, macrophages, and lymphocytes infiltrate the bronchial walls, causing epithelial injury and initiating a cascade of structural and functional changes.
Q2: How does squamous metaplasia affect the airways in chronic bronchitis?
Squamous metaplasia replaces the ciliated epithelium with non-ciliated squamous cells, impairing mucociliary clearance. This loss of ciliated cells reduces the airway's ability to trap and remove mucus and pathogens, increasing infection risk and allowing mucus to accumulate and damage airways progressively.
Q3: Why do goblet cells and submucosal glands enlarge in chronic bronchitis?
Persistent inflammation triggers hyperplasia and hypertrophy of goblet cells and submucosal glands. These enlarged structures produce excessive, thick mucus that clogs airways and promotes bacterial colonization. The increased Reid index reflects glands occupying over half the bronchial wall thickness, contributing to airflow obstruction.
Q4: What is the relationship between airway remodeling and breathing difficulty?
Airway remodeling includes smooth muscle hypertrophy, fibrosis, and inflammatory thickening that narrow airways, especially during expiration. Combined with mucus plugging, this obstruction causes air trapping and hyperinflation, which flattens the diaphragm, reduces tidal volume, and significantly increases the work of breathing.
Q5: How does chronic bronchitis impair gas exchange?
Airway obstruction and mucus plugging create a ventilation-perfusion mismatch where perfusion exceeds ventilation. This mismatch leads to hypoxemia and, in advanced cases, hypercapnia due to poor carbon dioxide clearance. Progressive airway damage reduces the lungs' ability to oxygenate blood and eliminate carbon dioxide effectively.
Q6: What are the main clinical symptoms of chronic bronchitis?
Chronic bronchitis presents with chronic productive cough, dyspnea, and frequent infections. These symptoms result from persistent airway inflammation, excessive mucus production, and impaired clearance mechanisms. Although lung parenchyma is relatively preserved compared to emphysema, progressive airway damage leads to declining lung function and worsening symptoms.
Q7: How does chronic bronchitis differ from emphysema in COPD?
Chronic bronchitis is characterized by airway-centered inflammation and mucus overproduction with relatively preserved lung parenchyma. In contrast, emphysema involves parenchymal destruction. Understanding both phenotypes is essential for recognizing that chronic obstructive pulmonary disease emphysema and chronic bronchitis represent distinct pathological processes within COPD.